Arbitration

Arbitration

This subtopic contains the following guidance on EU level rules relating to arbitration:

•
Practice Note: Intra-EU investment disputes—an introduction considers the regime for the resolution of intra-EU investment disputes in light of the Agreement for the termination of Bilateral Investment Treaties between the Member States of the European Union (the Termination Agreement or Termination Treaty or the EU plurilateral treaty) and the decision of the Court of Justice in Slovakia v Achmea (the Achmea case), Case C‑284/16. The Practice Note considers the background to the Termination Treaty and how investment disputes within the EU are to be resolved in accordance with its terms. This topic may be referred to as investment disputes

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

TAKE A FREE TRIAL

Latest EU Law News

Ireland-DPC fines TikTok €530m for GDPR breaches in China data transfers

The Irish Data Protection Commission (DPC) has imposed a €530m fine on TikTok Technology Limited (TikTok) for General Data Protection Board (GDPR) violations relating to EEA user data transfers to China. The decision was based on the finding that TikTok had breached Article 46(1) and Article 13(1)(f) of GDPR by failing to ensure adequate data protection levels and transparency requirements. The DPC ordered TikTok to achieve compliance within six months or face suspension of data transfers to China. The decision follows TikTok's admission of providing incorrect information about data storage on Chinese servers during the inquiry.

European Commission opens call for evidence to strengthen measures against online piracy of live events

The European Commission has published a framework that outlines its recommendation from 4 May 2023, aimed at combating online piracy of sports and live events. The publication urges Member States and stakeholders to adopt effective, proportionate measures against unauthorised retransmissions. In addition, the Commission has opened a call for evidence, with submissions invited from 30 April - 28 May 2025, to refine the initiative further. The effectiveness of the measures will be reviewed by 17 November 2025, based on insights from the EUIPO Observatory, with a final version anticipated in the fourth quarter of 2025.

'Vagisan' too close to 'vagisil' for EU Pharma Trade mark, court says

Law360, London: A German pharmaceutical company has failed to revive its efforts to get a trade mark for 'Vagisan' in the EU because of its likeness to rival feminine health product 'Vagisil'.

EMA updates competing interests policy for scientific committee members

The European Medicines Agency (EMA) has implemented revised policies for handling competing interests, effective from 1 May 2025. Policy 0044 for scientific committee members and Policy 58 for Management Board members introduce stricter restrictions on current interests, establish a unified three-year cooling-off period for past pharmaceutical industry employment, and strengthen oversight of medical device industry interests. The changes align both policies with Court of Justice rulings in joined Cases C-6/21 and C-16/21 P (Aplidin case) and Case C-291/22 P (D&A Pharma v Commission and EMA). The policy applies to all EMA scientific committees, working parties and bodies including the Emergency Task Force and Executive Steering Groups.